AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Elanix Biotechnologies AG

Declaration of Voting Results & Voting Rights Announcements Feb 20, 2018

136_dva_2018-02-20_542cc711-66f6-42cf-8552-8ca4c1b835c9.html

Declaration of Voting Results & Voting Rights Announcements

Open in Viewer

Opens in native device viewer

News Details

Total Voting Rights | 20 February 2018 13:29

Elanix Biotechnologies AG: Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

Elanix Biotechnologies AG / Total Voting Rights Announcement

20.02.2018 / 13:29

Total Voting Rights Announcement transmitted by DGAP – a service of EQS Group AG.

The issuer is solely responsible for the content of this announcement.


Publication of total number of voting rights

1. Details of issuerElanix Biotechnologies AG

Kurfürstendamm 32

10719 Berlin

Germany

2. Type of capital measure

Type of capital measure Date of status / date of effect
Conditional capital increase (Sec. 41 para. 2 WpHG)
X Other capital measure (Sec. 41 para. 1 WpHG) 19 Feb 2018

3. New total number of voting rights:****7099219


20.02.2018 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.

Archive at www.dgap.de


Language: English
Company: Elanix Biotechnologies AG
Kurfürstendamm 32
10719 Berlin
Germany
End of News DGAP News Service

show this

Talk to a Data Expert

Have a question? We'll get back to you promptly.